# AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

> **NCT01001091** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 312 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** AL-38583 ophthalmic solution
- **DRUG:** AL-38583 ophthalmic solution vehicle
- **DRUG:** Dexamethasone ophthalmic suspension, 0.1%

## Key facts

- **NCT ID:** NCT01001091
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2014-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001091, "AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01001091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*